Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study

BACKGROUND: Limited data are available on applying circulating tumor DNA (ctDNA) in metastatic triple-negative breast cancer (mTNBC) patients. Here, we investigated the value of ctDNA for predicting the prognosis and monitoring the treatment response in mTNBC patients. METHODS: We prospectively enro...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Yajing, Su, Mu, Zhou, Dongdong, Zheng, Fangchao, Zhang, Baoxuan, Qiang, Ling, Ren, Guohua, Song, Lihua, Bu, Bing, Fang, Shu, Yu, Bo, Zhou, Jinxing, Yu, Jinming, Li, Huihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627511/
https://www.ncbi.nlm.nih.gov/pubmed/37929934
http://dx.doi.org/10.7554/eLife.90198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627511/
https://www.ncbi.nlm.nih.gov/pubmed/37929934
http://dx.doi.org/10.7554/eLife.90198

Ejemplares similares